Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Archives of Gynecology and Obstetrics|September 10, 2013
Expression and significance of biglycan in endometrial cancerYang Liu, Weihua Li, Xin Li, et al.Cell Cycle (Georgetown, Tex.)|August 31, 2018
Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cellsSong Li, Jie Zhou, Hongying Wu, et al.BMC Cancer|November 14, 2023
PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapyXingyi Du, Xiaoyu Yi, Xiaocui Zou, et al.International Journal of Clinical and Experimental Pathology|December 1, 2015
Ectopic hamartomatous thymoma: report of a case and review of literatureHongbiao Jing, Jing Wang, Hong Wei, et al.Frontiers in Oncology|January 11, 2020
High Frequency of Cell-in-Cell Formation in Heterogeneous Human Breast Cancer Tissue in a Patient With Poor Prognosis: A Case Report and Literature ReviewBanzhan Ruan, Zubiao Niu, Xiaoyi Jiang, et al.Biomolecules & Biomedicine|August 16, 2024
Detecting cell types and densities in the tumor microenvironment improves prognostic risk assessment for breast cancerPu Liu, Xueli Zhang, Wenwen Wang, et al.Oncotargets and Therapy|April 5, 2018
miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effectWenpeng Liu, Lei Kang, Juqiang Han, et al.Oncotarget|March 20, 2018
Targeting stearoyl-CoA desaturase 1 to repress endometrial cancer progressionWeihua Li, Huimin Bai, Shiping Liu, et al.Journal of Cancer Research and Clinical Oncology|January 10, 2012
The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinomaChengying Jiang, Fangke Hu, Yanhong Tai, et al.Cancer Biology & Therapy|October 2, 2018
CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinibXue Du, Yun Shao, Hongjun Gao, et al.Pageof 5